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with and, if necessary, treated for knee cartilage defects by
arthroscopy at one of seven centres in Germany. Patients were
assigned to the initial operation (IO) group if the study physician
was able to conﬁrm that the study arthroscopy was the patient’s
ﬁrst surgical procedure ever on that particular knee. All other
patients were assigned to the re-operation (RO) group. Patients
were interviewed on their postsurgical outcome with two disease-
speciﬁc (Tegner Scale and IKDC Subjective Knee Form [IKDC-
SKF] including a retrospective assessment of their pre-surgical
health state) and a generic instrument (SF-36). RESULTS: Data
from a total of 1708 patients were included in the ﬁnal analysis.
Of these, 1070 were assigned to the initial operation (IO) group
(61% men, 49  15 years; 39% women, 52  14 years) and 638
were assigned to the re-operation (RO) group (64% men,
44  13 years; 36% women, 47  14 years). Participants expe-
rienced a level reduction of 1.5 (IO) and 2.5 (RO) resp. with the
Tegner scale. Patients reported a functional knee status measured
by the IKDC-SKF of 64% to 84% dependent on the surgical
procedure performed. Signiﬁcantly lower scores than the general
population were observed with the SF-36 for the physical func-
tioning, role-physical, and role-emotional scales, as well as for
the physical health summary measure. The strongest limitations
in the overall study population compared to the general popula-
tion were seen on the physical functioning, role-physical, and
role-emotional dimensions. In all three instruments the RO
group experienced more severe reductions in quality of life.
CONCLUSIONS: Despite extensive treatments participants
experienced lasting reductions in quality of life. Surgical proce-
dures differ in their long-term outcome. Longer history of inter-
ventions decrease the treatment related outcomes.
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OBJECTIVES: Total hip and knee replacement are very common
procedures. Both of them improve function, pain and health
related quality of life (HRQoL). The aim of this study was to
compare baseline scores and improvements at one year inHRQoL
according to the operated joint. METHODS: This prospective
observational study was carried out in 15 hospitals with consecu-
tive patients. All included patients fulﬁlled 3 HRQoL question-
naires at two times, 1 month pre surgery and 12 months post
surgery. There were 2 generic questionnaires; EQ-5D and SF-12
and one speciﬁc, the WOMAC. We compare the baseline scores
and improvements at one year by mean of Student’s t test.
RESULTS: The analysis was performed over 864 patients who
fulﬁlled the included questionnaires. There were 355 hips and 509
knees. Mean age (mean  s.d.) was not different between hip
(63.5  19.9) and knee (64.3  23.8) patients. At baseline,
patients who were waiting for hip replacement had only worse
score in the function dimension of WOMAC (64.8  16.6 vs
61.1  17.6) (p = 0.002). According to the improvements at one
year, there were statistically signiﬁcant differences in all EQ-5D
and WOMAC dimensions. The patients in the hip group experi-
enced higher improvements in EQ-5D index (p = 0.005), VAS
(p = 0.005), WOMAC pain (p < 0.001), function (p = 0.001) and
stiffness (p < 0.001). There were no statistically differences in the
improvements measured by SF-12. CONCLUSIONS: In the light
of these datawe can conclude that at baseline patients have similar
HRQoL scores, while at 1 year those who have undergone hip
replacement experienced a higher improvement in the affected
dimensions. In addition, the generic questionnaire SF-12 does not
seem to capture the changes in HRQoL in these patients.
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OBJECTIVES: To evaluate the effect of golimumab (GLM) on
self-reported productivity in rheumatoid arthritis (RA) patients.
METHODS:The effect of GLMon self-reported productivity was
evaluated in threemulticenter, randomized, double-blind, placebo
(PBO)-controlled studies in RA patients. Data from patients
receiving GLM or PBO with or without methotrexate (MTX) are
presented. The trials evaluated different patient populations and
included patients naïve to MTX (GO-BEFORE), patients with
active RA despite MTX (GO-FORWARD), and patients previ-
ously treated with anti-TNF-alpha agent(s) (GO-AFTER). GLM
subcutaneous injections of 50 mg or 100 mg were administered
q4wks. Atwks0 and 24, patientswere asked to indicate howmuch
their disease affected their productivity at work, school or at home
in the past 4wks using a 0 (did not affect productivity at all) to 10
(affected productivity very much) VAS scale. A negative mean
change from baseline is an improvement in self-reported produc-
tivity. An ANOVA on van der Waerden normal scores was per-
formed for between-group comparisons. RESULTS: In each of
the trials mean baseline scores for self-reported productivity
were comparable between groups (ranges were 6.3–6.4[GO-
BEFORE] 5.4–5.7[GO-FORWARD], 6.2–6.7[GO-AFTER]). In
GO-FORWARD, the mean(SD) improvements in self-reported
productivity were signiﬁcantly greater in the GLM50 and 100 mg
+ MTX groups compared with PBO + MTX at wk24 (-1.97 
3.12, -2.00  2.53, and -0.45  2.98, respectively, p < 0.001).
In GO-AFTER, the mean(SD) improvements in self-reported
productivity were signiﬁcantly greater in the GLM50 and 100 mg
groups compared with PBO at wk24 (-1.77  2.90, -2.10 
2.92, and -0.52  2.79, respectively, p < 0.001). In GO-
BEFORE, numerical improvements in self-reported productivity
were observed in the GLM 50 and 100 mg + MTX groups
(-2.48  2.94 and -2.90  2.80, respectively); these improve-
ments were not signiﬁcantly different from PBO + MTX
(-2.27  3.02). CONCLUSIONS: In two studies, GLM resulted
in signiﬁcant improvements in self-reported productivity. In the
third trial, GLM resulted in trends towards improvement in
self-reported productivity compared with PBO + MTX.
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OBJECTIVES: To evaluate welfare changes in individuals using
balloon kyphoplasty (BKP) for the treatment of vertebral body
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